Dr. Feldman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Edwards Lifesciences Corporation
One Edwards Way
Irvine, CA 92614Phone+1 949-250-4151
Education & Training
- University of ChicagoFellowship, Cardiovascular Disease, 1982 - 1985
- Rush University Medical CenterResidency, Internal Medicine, 1978 - 1982
- Indiana University School of MedicineClass of 1978
Certifications & Licensure
- IL State Medical License 1979 - 2026
- IN State Medical License 1978 - 2005
- OK State Medical License 1987 - 1989
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Join now to see all
Clinical Trials
- PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk Start of enrollment: 2011 Mar 01
- A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System Start of enrollment: 2012 Dec 01
- Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsTRISCEND II: Novel Randomized Trial Design for Transcatheter Tricuspid Valve Replacement.Paul A Grayburn, Susheel K Kodali, Rebecca T Hahn, Philipp Lurz, Vinod H Thourani
The American Journal of Cardiology. 2024-08-15 - 1 citationsMinimum Core Data Elements for Transcatheter Mitral Therapies: Scientific Statement by PASSION CV, HVC, and TVTR.Sreekanth Vemulapalli, Matheus Simonato, Ori Ben Yehuda, Changfu Wu, Ted Feldman
JACC. Cardiovascular Interventions. 2023-06-26 - 4 citations10 Years of SYNTAX: Closing an Era of Clinical Research After Identifying New Outcome Determinants.Patrick W Serruys, Pruthvi C Revaiah, Kai Ninomiya, Shinichiro Masuda, Nozomi Kotoku
JACC. Asia. 2023-06-01
Press Mentions
- National Coverage Determination Will Make TAVR Available to More Patients at More CentersAugust 12th, 2019
- Rightway Healthcare Announces Strategic Partnership with United Benefit AdvisorsJuly 25th, 2019
- Rightway Healthcare Raises $8.0 Million in Series A FundraisingFebruary 27th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: